Common IBD treatment blunts COVID-19 vaccine response
People who take a commonly prescribed drug for inflammatory bowel disease (IBD) should not assume they are protected after a first dose of COVID-19 vaccine, after a large-scale study found many had poor antibody responses.
Apr 26, 2021
0
9
